Rautenberg C, Middeke JM, Röllig C, Stelljes M, Gaidzik V, Kriege O, Verbeek M, Koch K, Unglaub JM, Thol F, Krause S, Hänel M, Neuerburg C, Vucinic V, Jehn CF, Wass M, Heuser M, Fransecky L, Chemnitz J, Holtick U, Schäfer-Eckart K, Schröder J, Kraus S, Krüger W, Kaiser U, Scholl S, Kobbe G, Jäger PS, Alakel N, von Bonin M, Sockel K, Hanoun M, Platzbecker U, Holderried TA, Morgner A, Sauer T, Götze KS, Wagner-Drouet E, Döhner K, Döhner H, Schliemann C, Schetelig J, Bornhäuser M, Germing U, Flossdorf S, Schroeder T, Stölzel F (2025)
Publication Type: Journal article
Publication year: 2025
Book Volume: 15
Article Number: 60
Journal Issue: 1
DOI: 10.1038/s41408-025-01274-0
APA:
Rautenberg, C., Middeke, J.M., Röllig, C., Stelljes, M., Gaidzik, V., Kriege, O.,... Stölzel, F. (2025). Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients. Blood Cancer Journal, 15(1). https://doi.org/10.1038/s41408-025-01274-0
MLA:
Rautenberg, Christina, et al. "Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients." Blood Cancer Journal 15.1 (2025).
BibTeX: Download